Validation of the INNO-LiPA HBV DR Assay (Version 2) in Monitoring Hepatitis B Virus-Infected Patients Receiving Nucleoside Analog Treatment

Hepatitis B virus (HBV) antiviral drug resistance mutations prevent successful outcome of treatment and lead to worsening of liver disease. Detection of its emergence permits opportune treatment with alternative drugs. Unfortunately, the use of newly approved antivirals, including adefovir dipivoxil...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Niesters, H. G. M., Zoulim, F., Pichoud, C., Buti, M., Shapiro, F., D'Heuvaert, N., Celis, L., Doutreloigne, J., Sablon, E.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology (ASM) 2010
Ämnen:
Antiviral Agents
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2826013/
https://ncbi.nlm.nih.gov/pubmed/20065049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00970-09
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk